• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素调节良性前列腺增生中初级基质细胞的增殖和炎症表达。

Estrogen regulates the proliferation and inflammatory expression of primary stromal cell in benign prostatic hyperplasia.

作者信息

Chen Bo, Cao Dehong, Chen Zeyu, Huang Yin, Lin Tianhai, Ai Jianzhong, Liu Liangren, Wei Qiang

机构信息

Department of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.

Institution of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.

出版信息

Transl Androl Urol. 2020 Apr;9(2):322-331. doi: 10.21037/tau.2020.02.08.

DOI:10.21037/tau.2020.02.08
PMID:32420138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7214965/
Abstract

BACKGROUND

To investigate the expression of estrogen receptor (ER) in prostate tissues of benign prostatic hyperplasia (BPH) individuals, and the effects of estrogen regulating the proliferation and inflammatory expressions of primary prostate stromal cells in BPH.

METHODS

A total of 44 human BPH prostate tissues were collected to explore the expression of ER by immunohistochemistry (IHC). Cell proliferation, mRNA and protein expressions were analyzed in primary prostate stromal cells treated with estrogen or estrogen plus fulvestrant through cell count kit-8 (CCK-8) assay, quantitative real-time polymerase chain reaction (qPCR), IHC and western blot, respectively.

RESULTS

Firstly, ERβ was positive, and ERα was negative in the transition zone of prostate among all the 44 individuals with BPH. Secondly, the effects could be partially inhibited by fulvestrant, of estrogen promoting the proliferation of primary prostate stromal cells cultured in dulbecco's modified eagle medium (DMEM) supplemented with 2% fetal bovine serum (FBS). Thirdly, estrogen up-regulates the mRNA levels of C-C chemokine receptor type 3 (CCR3), CD40 ligand (CD 40L), C-X-C motif chemokine ligand 9 (CXCL9) and interleukin 10 (IL10), and down-regulates the mRNA levels of C-C chemokine receptor type 4 (CCR4) and interleukin 17C (IL17C). Then, the protein expressions of CCR3, CCR4, CD40L, IL10 and IL17C are positive, and CXCL9 is negative in the third-generation primary prostate stromal cells. Finally, the effects could be partially inhibited by fulvestrant, of estrogen up-regulating the protein levels of CD40L and IL10.

CONCLUSIONS

The expressions of ER in human BPH prostate tissues are zone-dependent. Estrogen promoting the proliferation of primary prostate stromal cells cultured in DMEM supplemented with 2% FBS. The expressions of CCR3, CCR4, CD 40L, IL17C, CXCL9 and IL10 are regulated by estrogen in primary prostate stromal cells.

摘要

背景

研究雌激素受体(ER)在良性前列腺增生(BPH)患者前列腺组织中的表达,以及雌激素对BPH患者原代前列腺基质细胞增殖和炎症表达的影响。

方法

收集44例人BPH前列腺组织,采用免疫组织化学(IHC)法检测ER的表达。分别通过细胞计数试剂盒-8(CCK-8)法、定量实时聚合酶链反应(qPCR)、IHC和蛋白质印迹法分析雌激素或雌激素加氟维司群处理的原代前列腺基质细胞的细胞增殖、mRNA和蛋白质表达。

结果

首先,在所有44例BPH患者中,前列腺移行带中ERβ呈阳性,ERα呈阴性。其次,氟维司群可部分抑制雌激素促进在添加2%胎牛血清(FBS)的杜氏改良 Eagle培养基(DMEM)中培养的原代前列腺基质细胞增殖的作用。第三,雌激素上调C-C趋化因子受体3(CCR3)、CD40配体(CD40L)、C-X-C基序趋化因子配体9(CXCL9)和白细胞介素10(IL10)的mRNA水平,下调C-C趋化因子受体4(CCR4)和白细胞介素17C(IL17C)的mRNA水平。然后,在第三代原代前列腺基质细胞中,CCR3、CCR4、CD40L、IL10和IL17C的蛋白质表达呈阳性,CXCL9呈阴性。最后,氟维司群可部分抑制雌激素上调CD40L和IL10蛋白质水平的作用。

结论

人BPH前列腺组织中ER的表达具有区域依赖性。雌激素促进在添加2%FBS的DMEM中培养的原代前列腺基质细胞增殖。原代前列腺基质细胞中CCR3、CCR4、CD40L、IL17C、CXCL9和IL10的表达受雌激素调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8f/7214965/427175b3c177/tau-09-02-322-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8f/7214965/e0281194aed4/tau-09-02-322-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8f/7214965/66ab8b8a8bd9/tau-09-02-322-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8f/7214965/79643808010e/tau-09-02-322-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8f/7214965/8af3ce803416/tau-09-02-322-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8f/7214965/427175b3c177/tau-09-02-322-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8f/7214965/e0281194aed4/tau-09-02-322-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8f/7214965/66ab8b8a8bd9/tau-09-02-322-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8f/7214965/79643808010e/tau-09-02-322-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8f/7214965/8af3ce803416/tau-09-02-322-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8f/7214965/427175b3c177/tau-09-02-322-f5.jpg

相似文献

1
Estrogen regulates the proliferation and inflammatory expression of primary stromal cell in benign prostatic hyperplasia.雌激素调节良性前列腺增生中初级基质细胞的增殖和炎症表达。
Transl Androl Urol. 2020 Apr;9(2):322-331. doi: 10.21037/tau.2020.02.08.
2
Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.锁阳表现出类植物雌激素或类植物雄激素活性,通过调节类固醇 5-α-还原酶来减轻良性前列腺增生。
J Ethnopharmacol. 2019 May 10;235:65-74. doi: 10.1016/j.jep.2019.01.038. Epub 2019 Jan 29.
3
Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.在良性前列腺增生中,性类固醇受体的表达和定位随组织隔室而变化。
Differentiation. 2013 Apr-Jun;85(4-5):140-9. doi: 10.1016/j.diff.2013.02.006. Epub 2013 Jun 20.
4
TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via Akt/mTOR signaling.肿瘤坏死因子受体相关因子6通过Akt/哺乳动物雷帕霉素靶蛋白信号通路调节良性前列腺增生移行区和外周区基质细胞的增殖。
Prostate. 2018 Feb;78(3):193-201. doi: 10.1002/pros.23456. Epub 2017 Nov 23.
5
Macrophages affect immune inflammation and proliferation in benign prostatic hyperplasia via androgen receptor and CD40/CD40L signaling pathway.巨噬细胞通过雄激素受体和 CD40/CD40L 信号通路影响良性前列腺增生中的免疫炎症和增殖。
Tissue Cell. 2020 Jun;64:101343. doi: 10.1016/j.tice.2020.101343. Epub 2020 Jan 23.
6
Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.雄激素、雌激素和孕激素受体在良性前列腺增生中的差异表达。
Bosn J Basic Med Sci. 2016 Jul 2;16(3):201-8. doi: 10.17305/bjbms.2016.1209. Epub 2016 Jun 13.
7
Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.人源 T47D-ERβ 乳腺癌细胞,四环素依赖性 ERβ 表达,反映大鼠和人乳腺组织中 ERα/ERβ 比值。
Toxicol In Vitro. 2013 Sep;27(6):1753-61. doi: 10.1016/j.tiv.2013.04.014. Epub 2013 May 13.
8
Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell.阴道毛滴虫刺激良性前列腺增生上皮细胞通过与肥大细胞相互作用诱导前列腺基质细胞增殖
Prostate. 2016 Nov;76(15):1431-44. doi: 10.1002/pros.23227. Epub 2016 Jun 21.
9
[Impact of immune inflammation on the proliferation and apoptosis of benign prostatic hyperplasia cells].免疫炎症对良性前列腺增生细胞增殖和凋亡的影响
Zhonghua Nan Ke Xue. 2021 Oct 20;27(10):867-875.
10
Bakuchiol suppresses oestrogen/testosterone-induced Benign Prostatic Hyperplasia development through up-regulation of epithelial estrogen receptor β and down-regulation of stromal aromatase.补骨脂酚通过上调上皮雌激素受体β和下调基质芳香酶抑制雌/雄激素诱导的良性前列腺增生发展。
Toxicol Appl Pharmacol. 2019 Oct 15;381:114637. doi: 10.1016/j.taap.2019.114637. Epub 2019 Jun 22.

引用本文的文献

1
Chemopreventive Potential of Paddy Waste: A Promising Approach Against Benign Prostate Hyperplasia in Spontaneously Hypertensive Rats.稻谷废弃物的化学预防潜力:一种针对自发性高血压大鼠良性前列腺增生的有前景的方法。
Anal Cell Pathol (Amst). 2025 Mar 13;2025:4029625. doi: 10.1155/ancp/4029625. eCollection 2025.
2
A Systematic Review of Medical Treatments for Benign Prostatic Hyperplasia in Dogs: Evaluating Strategies for Reproductive Function Preservation.犬良性前列腺增生症医学治疗的系统评价:评估生殖功能保留策略。
Vet Sci. 2025 Jan 19;12(1):70. doi: 10.3390/vetsci12010070.
3
Comprehensive RNA-seq analysis of benign prostatic hyperplasia (BPH) in rats exposed to testosterone and estradiol.

本文引用的文献

1
Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.良性前列腺增生症管理的流行病学与治疗方式
Transl Androl Urol. 2019 Oct;8(5):529-539. doi: 10.21037/tau.2019.10.01.
2
Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?A型肉毒杆菌毒素能否通过抑制慢性前列腺炎仍在治疗下尿路症状/良性前列腺增生中发挥作用?
Toxins (Basel). 2019 Sep 19;11(9):547. doi: 10.3390/toxins11090547.
3
Bakuchiol suppresses oestrogen/testosterone-induced Benign Prostatic Hyperplasia development through up-regulation of epithelial estrogen receptor β and down-regulation of stromal aromatase.
对暴露于睾酮和雌二醇的大鼠良性前列腺增生(BPH)进行的综合RNA测序分析。
Sci Rep. 2025 Jan 22;15(1):2750. doi: 10.1038/s41598-025-87205-2.
4
The Effects of Caloric Restriction on Inflammatory Targets in the Prostates of Aged Rats.热量限制对老年大鼠前列腺中炎症靶点的影响。
Int J Mol Sci. 2024 May 11;25(10):5236. doi: 10.3390/ijms25105236.
5
Comparative RNA-sequencing analysis of the prostate in a mouse model of benign prostatic hyperplasia with bladder outlet obstruction.良性前列腺增生伴膀胱出口梗阻小鼠模型前列腺的比较 RNA 测序分析。
Mol Cell Biochem. 2023 Dec;478(12):2721-2737. doi: 10.1007/s11010-023-04695-2. Epub 2023 Mar 15.
6
Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia.miR-1199-5p 的上调与良性前列腺增生中 2 型 5-α 还原酶表达降低有关。
BMC Urol. 2022 Nov 7;22(1):172. doi: 10.1186/s12894-022-01121-5.
7
Phosphoproteomics identifies potential downstream targets of the integrin α2β1 inhibitor BTT-3033 in prostate stromal cells.磷酸化蛋白质组学鉴定整合素α2β1抑制剂BTT-3033在前列腺基质细胞中的潜在下游靶点。
Ann Transl Med. 2021 Sep;9(17):1380. doi: 10.21037/atm-21-3194.
8
Investigation of Lymphocyte Subsets in Peripheral Blood of Patients with Benign Prostatic Hyperplasia.良性前列腺增生患者外周血淋巴细胞亚群的研究
Int J Gen Med. 2021 Oct 20;14:6951-6959. doi: 10.2147/IJGM.S340018. eCollection 2021.
9
A randomized placebo-controlled study: Phellodendron Bawei tablets combined with standard management can improve storage symptoms, sleep quality, and medication compliance in patients with benign prostatic hyperplasia compared to placebo with standard management.一项随机安慰剂对照研究:与采用标准治疗的安慰剂相比,八味黄柏片联合标准治疗可改善良性前列腺增生患者的储尿期症状、睡眠质量及用药依从性。
Transl Androl Urol. 2021 Aug;10(8):3423-3431. doi: 10.21037/tau-21-588.
补骨脂酚通过上调上皮雌激素受体β和下调基质芳香酶抑制雌/雄激素诱导的良性前列腺增生发展。
Toxicol Appl Pharmacol. 2019 Oct 15;381:114637. doi: 10.1016/j.taap.2019.114637. Epub 2019 Jun 22.
4
Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study.中国良性前列腺增生症(LUTS/BPH)下尿路症状患病率:来自中国健康与养老追踪调查的结果。
BMJ Open. 2019 Jun 19;9(6):e022792. doi: 10.1136/bmjopen-2018-022792.
5
Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia.CCL2、CCR2 和 CCL5 基因多态性与良性前列腺增生的发生和发展的关系。
Oncol Rep. 2019 Apr;41(4):2491-2501. doi: 10.3892/or.2019.7002. Epub 2019 Feb 6.
6
Testosterone and Benign Prostatic Hyperplasia.睾酮与良性前列腺增生。
Sex Med Rev. 2019 Apr;7(2):259-271. doi: 10.1016/j.sxmr.2018.10.006. Epub 2019 Feb 22.
7
Sex hormones and oxidative stress mediated phthalate-induced effects in prostatic enlargement.性激素和氧化应激介导的邻苯二甲酸酯诱导的前列腺增生作用。
Environ Int. 2019 May;126:184-192. doi: 10.1016/j.envint.2019.02.006. Epub 2019 Feb 22.
8
Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia.白细胞介素21受体上调增强良性前列腺增生中的增殖及上皮-间质转化过程
Front Endocrinol (Lausanne). 2019 Jan 23;10:4. doi: 10.3389/fendo.2019.00004. eCollection 2019.
9
Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).不同天然提取物对良性前列腺增生(BPH)实验模型的影响。
Inflamm Res. 2018 Jul;67(7):617-626. doi: 10.1007/s00011-018-1152-9. Epub 2018 Apr 20.
10
Differential research of inflammatory and related mediators in BPH, histological prostatitis and PCa.良性前列腺增生、组织学前列腺炎和前列腺癌中炎症及相关介质的差异研究。
Andrologia. 2018 Feb 14. doi: 10.1111/and.12974.